Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
http://img.marketwire.com/rss/mwPBES.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  common stock  company  hantian  health  jan  marketwired jan  marketwired  offering  otc pink  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies



Marketwired - Equipment and Supplies



Last Build Date: Fri, 20 Jan 2017 09:25:41 EST

Copyright: Copyright: (C) Marketwired
 



Progressive Care Beats Expectations with over $18 Million in 2016 Revenues

Fri, 20 Jan 2017 08:30:00 EST

MIAMI, FL--(Marketwired - January 20, 2017) - Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record breaking 2016.




Rennova Health's Pharmacogenomics Subsidiary Granted Patent

Fri, 20 Jan 2017 08:30:00 EST

WEST PALM BEACH, FL--(Marketwired - January 20, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that its Genomas, Inc. pharmacogenomics subsidiary has been granted a Patent by the US Patent and Trademark Office.




New Xtalks Webinar on Clinical Evaluation Reports (CERs): Global Benefits and The Impact of MEDDEV Updates to Manufacturers

Fri, 20 Jan 2017 07:30:00 EST

During a live broadcast, the speaker will examine the requirements listed in MEDDEV 2.7/1 revision. 4, discuss notable changes from MEDDEV 2.7/1 revision 3, while focusing on the global benefits of the Clinical Evaluation Report for your product's path to market.




Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer

Thu, 19 Jan 2017 18:07:57 EST

SYDNEY, AUSTRALIA--(Marketwired - Jan 19, 2017) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced the first patient has been dosed as part of the enlarged randomised phase of its AIPAC Phase IIb clinical trial for IMP321 in metastatic breast cancer.




Newly Created Standards Coordinating Body Seeks to Advance Development and Establishment of Regenerative Medicine Standards

Thu, 19 Jan 2017 15:23:19 EST

Builds upon call for standards development in 21st Century Cures Act




The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

Thu, 19 Jan 2017 12:22:41 EST

Builds upon call for standards development in 21st Century Cures Act




UPDATE - Greenhouse Solutions, Inc. Issues Company Update

Thu, 19 Jan 2017 12:05:47 EST

GREENWOOD VILLAGE, CO--(Marketwired - Jan 19, 2017) -  Greenhouse Solutions, Inc. (OTC PINK: GRSU) ("GH Solutions"), a company focused on creating and offering nutritional products with hemp supplements, is pleased to provide a Distributor Update and news on a distribution improvement that is being implemeted to the KOIOS Raspberry Wonder with Hemp beverage.




Capha Pharmaceuticals to Focus on Medical Marijuana Industry Under Leadership of Kyle J. Remenda President & COO

Thu, 19 Jan 2017 10:00:00 EST

WEST KELOWNA, BC--(Marketwired - January 19, 2017) - CAPHA PHARMACEUTICALS INC. ("Capha" and/or the "Company") is pleased to announce that the Company will be focusing on the medical marijuana industry under the leadership of Kyle J. Remenda, the Company's recently appointed President & COO.




Somnia Anesthesia Hosts Its CRNA of the Year Contest During CRNA Week

Thu, 19 Jan 2017 10:00:00 EST

Nominations for Somnia's Sixth Annual CRNA of the Year Award Now Open




Amedica Announces Pricing of Public Offering to Raise $4.5 Million

Thu, 19 Jan 2017 09:46:33 EST

SALT LAKE CITY, UT--(Marketwired - Jan 19, 2017) -  Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced the pricing of an underwritten public offering of common stock and warrants with a public offering price of $0.51 for one share of common stock and 0.45 warrants. Each whole warrant is exercisable for one share of common stock. The Company expects to receive gross proceeds of approximately $4.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The Company has also granted a 45-day option to the underwriters to purchase up to an additional 15% of the shares of common stock plus up to 15% of the warrants; provided that in no event may the aggregate market value of securities sold in the offering, including from the over-allotment option, exceed the limitations set forth in Rule I.B.6 of Form S-3 solely to cover over-allotments, if any.




Vaxil Bio Expands Into Infectious Diseases With First US Patent for MTbuVax(TM)

Thu, 19 Jan 2017 09:30:00 EST

Receives USPTO Notice of Allowance for MTbuVax(TM) Family of Signal Peptide Vaccines and their use in Treating Major Infectious Diseases




AssistRx Acquires Caret(TM), Providing Users with Cutting Edge Technology to Boost Patient Care Management, Adherence, and Compliance

Thu, 19 Jan 2017 09:01:00 EST

ORLANDO, FL--(Marketwired - Jan 19, 2017) -  AssistRx (ARx), the leading enterprise technology platform focused on simplifying the patient journey for specialty and highly-managed medications, today announces its acquisition of Caret, and Caret's Care Management Platform. Caret provides healthcare providers, specialty pharmacies, patients, and payers a best-in-class communication platform powered by actionable data such as point-of-service decision making, care management programs and near real-time updates on patients. ARx plans to integrate these features into the AssistRx Platform, to enhance the patient journey, drive quality-based healthcare, and improve outcomes.




InMed Pharma Appoints Eli Lilly Finance Executive to Board of Directors -- CFN Media

Thu, 19 Jan 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s (OTCQB: IMLFF) (CNSX: IN) recent appointment of Martin Bott to its Board of Directors, the company's existing team, and what it means as InMed progresses towards its first clinical trial in INM-750 for the treatment of Epidermolysis Bullosa as well as the rest of its clinical pipeline.




AXIM Biotech Begins CanChew Plus Clinical Trials -- SECFilings.com

Thu, 19 Jan 2017 09:00:00 EST

REDONDO BEACH, CA--(Marketwired - Jan 19, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc.'s (OTCQB: AXIM) recently announced clinical trials evaluating its CanChew Plus® cannabidiol (CBD) gum for the treatment of irritable bowel syndrome (IBS).




Vertical Integration of CRISPR/Cas9 Genome Engineering in Drug Discovery, New Webinar Hosted by Xtalks

Thu, 19 Jan 2017 07:30:00 EST

TORONTO, ON--(Marketwired - January 19, 2017) - Industry expert Dr. Anne-Marie Zuurmond, Associate Director of Genome Engineering, Discovery, Charles River Laboratories will discuss several CRISPR/Cas9 case studies during this webinar covering different aspects of the drug discovery process with an emphasis on the generation of in vitro models for high-throughput screening and the creation of new mouse models of disease.




Nutritional High Announces Inclusion Into U.S. Marijuana Index

Thu, 19 Jan 2017 07:30:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 19, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce that it has been added to the U.S. Marijuana Index.




Moleculin Announces Expanded Scientific Advisory Board

Thu, 19 Jan 2017 07:00:00 EST

HOUSTON, TX--(Marketwired - January 19, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced that Drs. Sandra Silberman and Paul Waymack have joined the Company's Scientific Advisory Board (SAB). The Company's current SAB also includes Dr. Waldemar Priebe (Chair) and Dr. Madeleine Duvic.




Optymyze Takes the Gold in Brandon Hall Group's 2016 Excellence in Technology Awards

Thu, 19 Jan 2017 07:00:00 EST

Optymyze Sales Operations is Recognized for Best Advance in Sales Enablement and Performance Tools




Proto Script Pharmaceutical Corp. Building New Partnerships with Independent Practice Associations (IPA)

Thu, 19 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 19, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, today provided this update regarding its current business and future expansion plans with Independent Practice Associations.




Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017

Wed, 18 Jan 2017 16:05:00 EST

HERCULES, CA--(Marketwired - Jan 18, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2016 on Thursday, February 23, 2017, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.




Amedica Announces Proposed Public Offering of Common Stock and Warrants

Wed, 18 Jan 2017 16:01:00 EST

SALT LAKE CITY, UT--(Marketwired - Jan 18, 2017) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in an underwritten public offering. The common stock and warrants are being offered under the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission (SEC). Net proceeds from the offering will be used by Amedica to (1) remain in compliance with the financial covenants in its outstanding Loan and Security Agreement; (2) support working capital needs and other general corporate purposes; (3) fund research and development and commercialization activities of Amedica's product candidates, including the funding of clinical trials Amedica plans to conduct for its product candidates; and (4) continue to build sales, marketing and distribution capabilities for Amedica's silicon nitride technology platform and other products, including the costs of inventory and instruments.




PHZIO Telehealth Webinar Link

Wed, 18 Jan 2017 13:30:36 EST

CULVER CITY, CA--(Marketwired - Jan 18, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company successfully held its initial webinar this morning. Please see the following link to view this webinar: https://wnarchives.s3.amazonaws.com/45426582/62c11c14-baa2-4ad7-b8cd-521b38fd3542/archive.mp4. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Megadyne Medical Named Utah's Most Innovative PR & Marketing Team 2016

Wed, 18 Jan 2017 13:00:00 EST

DRAPER, UT--(Marketwired - January 18, 2017) - Megadyne Medical Products, The Electrosurgical Authority® and full-solution electrosurgical provider, was recently named Utah's Most Innovative PR & Marketing Team 2016 by Corporate America News magazine. According to the online publication based in New York City, this prestigious award was granted to the medical device company based on its impressive presence across media, as well as client recommendations and referrals from other agencies who have witnessed the impact of Megadyne through its various PR and marketing initiatives.




Brown Technical Media Corp. Announces Uplist to the QB Tier of the OTC Markets

Wed, 18 Jan 2017 10:30:00 EST

HOUSTON, TX--(Marketwired - Jan 18, 2017) - Brown Technical Media Corp., a division of Panther Biotechnology Inc. (OTCQB: PBYA), an e-commerce company building the first full service training and career advancement brand for the skilled trades, is pleased to announce today that it has been accepted for up listing to the OTCQB effective immediately.




Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products

Wed, 18 Jan 2017 10:15:00 EST

EL PASO, TX--(Marketwired - Jan 18, 2017) - Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has signed a distribution agreement contract with the Pain Relief & Wellness Strategy Center in Grove City, Pennsylvania to sell and distribute its pain relief products. Initially, the contract will cover pain relief patches and roll-ons, but will expand as new products are introduced.




EAG Laboratories Adds New Capabilities in Dermal Absorption Testing

Wed, 18 Jan 2017 09:00:00 EST

HERCULES, CA--(Marketwired - Jan 18, 2017) - EAG Laboratories, a global scientific services company that provides testing, analytical and characterization services to technology- and life-science-related industries, announced the addition of dermal absorption studies to its suite of GLP-compliant testing services. The company now offers testing outlined in OECD 427 (in vivo studies in rodent models) and OECD 428 (in vitro studies using human and animal skin), which are often performed in parallel to predict dermal absorption in humans (sometimes called "the triple pack" or "parallelogram" approach).




VPR Brands, LP will be Re-Launching the STINGER at the BIG Industry in Los Angeles California

Wed, 18 Jan 2017 08:30:00 EST

FORT LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the 2017 Big Industry Show in Los Angeles, California on January 19-20th where we will be showcasing our flagship product, the STINGER, part of our Honey Stick Brand.




Vinergy Resources/MJ Biopharma Appoint Scientific Advisory Board Chair to Pursue Clinical Testing of Cannabinoids for Therapeutics

Wed, 18 Jan 2017 08:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 18, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(CSE:VIN.CN) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it has appointed Dr. William Panenka, MD as Chair of the Company's Scientific Advisory Board (SAB). Bringing on the right human capital through strategic hires is an important part of the Company's strategy to develop, test and identify specific cannabinoid isolates for targeted therapeutic purposes.




Upcoming Webinar on Development by Design: Hovione's Approach to Spray Drying Process Development

Wed, 18 Jan 2017 07:30:00 EST

TORONTO, ON--(Marketwired - January 18, 2017) - On Tuesday, January 31, 2017, Xtalks will host a complimentary webinar featuring Márcio Temtem, Associate Director of Particle Design and Formulation Development at Hovione and João Vicente, Team Leader of Particle Engineering and Solubility Enhancement at Hovione, as the keynote speakers.




MediXall Appoints Dr. Pedro A. Sanchez, D.O., to be its First Medical Director

Wed, 18 Jan 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.




Omni Health, Inc. names Andrey Soloviev as New CEO

Wed, 18 Jan 2017 07:25:04 EST

MIAMI, FL--(Marketwired - Jan 18, 2017) -  Omni Health, Inc., (OTC PINK: OMHE), a pharmaceutical company, announced today the Board of Directors has selected Andrey Soloviev as its new Chief Executive Officer. Mr. Soloviev will take over, effective immediately, for interim CEO, Michael Hawkins, who shall remain the company's interim CFO. 




Adam Equipment Introduces Approved Version of Highland(R) Portable Precision Balance

Wed, 18 Jan 2017 03:44:00 EST

EC Type/OIML-approved portable precision balances legal for trade use




Prima BioMed to Maintain NASDAQ Listing

Wed, 18 Jan 2017 02:02:58 EST

SYDNEY, AUSTRALIA--(Marketwired - Jan 18, 2017) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) the "Company" has received notification from the Listing Qualifications Department of the NASDAQ Stock Market indicating that the Company's American Depositary Shares have maintained a closing bid price of US$1.00 per share or greater for 10 consecutive business days from 28 December 2016 to 11 January 2017. Accordingly, the Company has regained compliance with NASDAQ Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule") and the Company's American Depositary Shares will remain listed on the NASDAQ Global Market.




FPS Pharma Changes Name to Capha Pharmaceuticals Inc.

Tue, 17 Jan 2017 11:10:05 EST

Kyle J. Remenda Appointed President & COO




Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai

Tue, 17 Jan 2017 11:00:00 EST

FREEHOLD, NJ--(Marketwired - Jan 17, 2017) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding its previous announcement about international sales for its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.




Health Advance Announces the Closing of the Acquisition of Hantian Labs

Tue, 17 Jan 2017 10:45:10 EST

LAS VEGAS, NV--(Marketwired - Jan 17, 2017) -  Health Advance Inc. (the "Company") (OTC PINK: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement ("Agreement") to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). As a result of the acquisition, Health Advance will also control 99% of JT Hantian LLC representing the revenue arm of Hantian. Pursuant to the Agreement, the Company has issued 18,000,000 common shares of the Company to the shareholders of Hantian Labs representing the purchase price of Hantian. Accordingly, the Company's issued and outstanding number of common shares increased from 26,520,000 shares to 44,520,000 shares. In addition, Company has waived Hantian's undertaking to raise a minimum financing of $250,000 for marketing of Hantian's product line prior to closing.




CORRECTION - Endexx Corporation

Tue, 17 Jan 2017 09:49:41 EST

CAVE CREEK, AZ--(Marketwired - Jan 17, 2017) - In the news release issued earlier today by Endexx Corporation (OTC PINK: EDXC), we are advised by the company the headline should read, "Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listing" rather than "Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listin" as originally issued. Complete corrected text follows.




GeoVax to Collaborate with Georgia State University on Development of Therapeutic Hepatitis B Vaccine

Tue, 17 Jan 2017 09:00:00 EST

Targeting Chronic Hepatitis B Infections Affecting More Than 240 Million People Worldwide




PHZIO Telehealth Clinic Orientation and On-boarding

Tue, 17 Jan 2017 09:00:00 EST

CULVER CITY, CA--(Marketwired - Jan 17, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company is pleased to announce that it has begun clinic orientation and on-boarding of selected PT's at Motion PT Group and our other previously announced PT clinic licensees. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Advanced Proteome Therapeutics Corporation Announces Issuance of U.S. Patent Covering Novel Molecules for the Treatment of Cancer

Tue, 17 Jan 2017 09:00:00 EST

VANCOUVER, BC--(Marketwired - January 17, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce issuance of APC's U.S. Patent Application 14/400,190 titled "Site-Specific Labeling and Targeted Delivery of Proteins for the Treatment of Cancer".




Progressive Care: PharmCo Opens Resource Center in Century Village

Tue, 17 Jan 2017 08:30:00 EST

MIAMI, FL--(Marketwired - January 17, 2017) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces a new Resource Center for the exclusive use for residents of Century Village of Pembroke Pines, FL.




MJTV Completes the Spin Off of BullsNBears Holdings, Inc. Eliminating more than $1,000,000 In Debt and Liabilities from MJTV's Books

Tue, 17 Jan 2017 08:00:00 EST

WHIPPANY, NJ--(Marketwired - Jan 17, 2017) - Michael James Enterprises, Inc. (OTCQB: MJTV) is pleased to report that it has eliminated more than $1,000,0000 of debt and liabilities with the spin off of BullsNBears Holdings, Inc. on December 27, 2016.




Endexx Engages Turner, Stone & Company as Auditor and Eilers Law Group to Prepare for Up Listin

Tue, 17 Jan 2017 08:00:00 EST

CAVE CREEK, AZ--(Marketwired - Jan 17, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient based food and nutritional products, today announced that it has engaged Turner, Stone & Company LLP and has initiated audits for its fiscal 2015 and 2016. The audit will bring current Endexx's financials for the past four years. In addition, Eilers Law Group will then file all SEC documents on behalf of Endexx to bring the company to fully audited status and in full compliance with the SEC.




Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment, an Industrial Info News Alert

Tue, 17 Jan 2017 07:30:00 EST

SUGAR LAND, TX--(Marketwired - Jan 17, 2017) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When many people hear the word "Texas," it evokes a number of clichés, typically a mélange of cattle, chemical plants, oil and gas drilling, and rodeos. But that sells the state short, for beyond the smoke stacks of the hundreds of the state's chemical processing plants and refineries are a surprising number of life-science manufacturing plants and research centers.




Greenhouse Solutions, Inc. Issues Company Update

Tue, 17 Jan 2017 07:30:00 EST

GREENWOOD VILLAGE, CO--(Marketwired - Jan 17, 2017) - Greenhouse Solutions, Inc. (OTC PINK: GRSU) ("GH Solutions"), a company focused on creating and offering nutritional products with hemp supplements, is pleased to provide a Distributor Update and news on a distribution improvement that is being implemeted to the KOIOS Raspberry Wonder with Hemp beverage.




Nutritional High Announces Launch of New Website

Tue, 17 Jan 2017 07:30:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce the launch of its new and completely redesigned website www.nutritionalhigh.com. The revamped website provides quick and easy access to essential information that offers an understanding of the Nutritional High's vision as well as the milestones accomplished by Nutritional High.




Study Shows Improved Primary Adherence as high as 99% using InstyMeds Automated Direct-to-Patient Dispensers

Tue, 17 Jan 2017 07:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Jan 17, 2017) - A 2017 study conducted at the University of Minnesota and published in the journal ClinicoEconomics and Outcomes Research found patients that have their medications dispensed at the point of care have much higher rates of adherence.




Proto Script Pharmaceutical Corp. discusses Opportunities in the Expanding US Power Wheelchair and Mobility Scooter Market

Tue, 17 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 17, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to provide this discussion regarding opportunities in the expanding US power wheelchair and mobility scooter market.




Rennova Health Completes Asset Purchase Agreement of Scott County Community Hospital

Tue, 17 Jan 2017 06:00:00 EST

WEST PALM BEACH, FL--(Marketwired - January 17, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that it has closed the previously reported Asset Purchase Agreement to acquire certain assets related to Scott County Community Hospital, based in Oneida, Tennessee ("Scott County Hospital").




Phoseon Technology se lance sur le marché de la biologie

Tue, 17 Jan 2017 00:00:00 EST

Nouvel accent et nouvelles possibilités pour la technologie LED brevetée




Phoseon Technology steigt in den Life-Sciences-Markt ein

Tue, 17 Jan 2017 00:00:00 EST

Neuer Schwerpunkt und neue Möglichkeiten für patentierte LED-Technologie




Phoseon Technology Enters Life Sciences Market

Tue, 17 Jan 2017 00:00:00 EST

New focus and capabilities for patented LED Technology




FPS Pharma Changes Name to Capha Pharmaceuticals Inc.

Mon, 16 Jan 2017 13:39:12 EST

Kyle J. Remenda Appointed President & COO




SpeeDx and UgenTec launch FastFinder for ResistancePlus MG Test

Mon, 16 Jan 2017 10:03:46 EST

Artificially intelligent interpretation module automatically incorporates test results into lab information systems




Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs

Mon, 16 Jan 2017 09:00:00 EST

LAS VEGAS, NV--(Marketwired - Jan 16, 2017) - Health Advance Inc. (the "Company") (OTC PINK: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement ("Agreement") to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). As a result of the acquisition, Health Advance will also control 99% of JT Hantian LLC representing the revenue arm of Hantian. Pursuant to the Agreement, the Company has issued 18,000,000 common shares of the Company to the shareholders of Hantian Labs representing the purchase price of Hantian. Accordingly, the Company's issued and outstanding number of common shares increased from 26,520,000 shares to 44,520,000 shares. In addition, Company has waived Hantian's undertaking to raise a minimum financing of $250,000 for marketing of Hantian's product line prior to closing.




Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property

Mon, 16 Jan 2017 08:30:00 EST

HERCULES, CA--(Marketwired - Jan 16, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, announced today that it has entered into a definitive agreement to purchase RainDance Technologies, Inc. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during the first quarter of 2017. The company will discuss the acquisition further during Bio-Rad's upcoming fourth-quarter and full-year 2016 financial results conference call. 




Akers Biosciences Announces Closing of Public Offering

Fri, 13 Jan 2017 16:21:09 EST

THOROFARE, NJ--(Marketwired - Jan 13, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, today announces the closing of its previously announced underwritten public offering of 1,667,000 shares of common stock at a public offering price of $1.20 per share together with the issuance of 833,500 five-year warrants to purchase common stock with an exercise price of $1.50. In addition, the underwriters exercised the over-allotment option to purchase an additional 122,500 shares of common stock and 61,250 warrants to purchase common stock. The gross proceeds from the offering, excluding any proceeds on the exercise of the warrants, are expected to be approximately $2,147,400, before deducting the underwriting discount and estimated offering expenses. The funds raised will be used for working capital as well as to accelerate growth in the US and in international markets, further develop new customers and launch new diagnostic products.